Accurately measuring pain in humans and rodents is essential to unravel the neurobiology of pain and discover effective pain therapeutics. However, given its inherently subjective nature, pain is nearly impossible to objectively assess. In the clinic, patients can articulate their pain experience using questionnaires and pain scales but self-reporting can be unreliable due to various psychological and social influences or difficulties for some patients to verbalize their experience (eg, infants, toddlers, and those with neurodevelopmental disorders). At the bench, these challenges are even more daunting as researchers rely on the behaviors of rodents to measure pain or pain relief. Given this, there is a growing realization among pain researchers, clinicians, and funding entities that these traditional approaches of assessing pain in rodents may be flawed. Importantly, these flaws may have contributed to several failed drugs that initially showed promise as analgesics and point toward inconsistencies in our understanding of basic pain neurobiology
